Achilles Therapeutics plc Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Achilles Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Achilles Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.31M, a 22.9% decline year-over-year.
  • Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2023 was $6.36M, a 9.47% decline from 2022.
  • Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $7.02M, a 11.2% increase from 2021.
  • Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $6.32M, a 111% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.36M -$665K -9.47% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-04
2022 $7.02M +$705K +11.2% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-04
2021 $6.32M +$3.33M +111% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-04
2020 $2.99M +$2.27M +316% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 $719K Jan 1, 2019 Dec 31, 2019 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.